These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 434566)
41. Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension. Hollenberg NK; Swartz SL; Passan DR; Williams GH N Engl J Med; 1979 Jul; 301(1):9-12. PubMed ID: 221809 [TBL] [Abstract][Full Text] [Related]
42. Angiotensin II: evidence for its role as an intrarenal hormone. Mendelsohn FA Kidney Int Suppl; 1982 Aug; 12():S78-81. PubMed ID: 6182339 [TBL] [Abstract][Full Text] [Related]
43. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)]. Shionoiri H; Uneda S; Tochikubo O; Ohonishi T; Harada J; Sesoko S; Goto E; Fujishima S; Kaneko Y Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):13-22. PubMed ID: 6247528 [No Abstract] [Full Text] [Related]
44. [Effects of angiotensin I converting enzyme inhibitor (captopril) on blood pressure, pulse rate, plasma renin activity, and plasma aldosterone concentration in patients with essential hypertension and normal subjects]. Seto S; Kaku T; Shinagawa T; Matsumoto Y; Doi Y; Tasaki S; Murayama M; Aoi W; Kuramochi M; Hashiba K Nihon Naika Gakkai Zasshi; 1980 Nov; 69(11):1439-46. PubMed ID: 7017040 [No Abstract] [Full Text] [Related]
45. Comparison between saralsin and converting enzyme inhibitor in hypertensive disease. Case DB; Wallace JM; Laragh JH Kidney Int Suppl; 1979 Mar; (9):S107-114. PubMed ID: 225598 [No Abstract] [Full Text] [Related]
46. Aspirin test for differentiation of unilateral renovascular hypertension from hyperreninemic essential hypertension. Imanishi M; Ohta M; Kawamura M; Akabane S; Matsushima Y; Kuramochi M; Kojima S; Kimura K; Takamiya M; Ito K Am J Hypertens; 1991 Sep; 4(9):761-8. PubMed ID: 1930860 [TBL] [Abstract][Full Text] [Related]
47. Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme. Case DB; Wallace JM; Keim HJ; Weber MA; Sealey JE; Laragh JH N Engl J Med; 1977 Mar; 296(12):641-6. PubMed ID: 190537 [TBL] [Abstract][Full Text] [Related]
48. Hypertension, the adrenal and the kidney: lessons from pharmacologic interruption of the renin-angiotensin system. Hollenberg NK; Williams GH Adv Intern Med; 1980; 25():327-61. PubMed ID: 6153859 [No Abstract] [Full Text] [Related]
49. Peripheral and renal vein renin activity in patients with renovascular hypertension due to nonspecific aortoarteritis. Lall SB; Dave V; Dash SC; Bhargava S Angiology; 1991 Dec; 42(12):979-84. PubMed ID: 1763831 [TBL] [Abstract][Full Text] [Related]
50. Clinical significance of plasma renin activity in human renovascular hypertension. Salvetti A; Arzilli F; Sassano P; Poli L; Pesola A Clin Sci Mol Med Suppl; 1976 Dec; 3():239s-242s. PubMed ID: 1071617 [TBL] [Abstract][Full Text] [Related]
51. [Different reaction of plasma renin activity after propranolol in essential and renal hypertension]. Skrabal F Klin Wochenschr; 1975 Jul; 53(13):629-32. PubMed ID: 1177407 [TBL] [Abstract][Full Text] [Related]
52. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension. Browne GA; Griffin TP; O'Shea PM; Dennedy MC Clin Endocrinol (Oxf); 2016 Mar; 84(3):325-31. PubMed ID: 26300226 [TBL] [Abstract][Full Text] [Related]
53. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system. Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244 [TBL] [Abstract][Full Text] [Related]
54. Acute hypertension in a nonhuman primate: humoral and hemodynamic mechanisms. Cody RJ; Rodger RF; Hartley LH; Burton J; Herd JA Hypertension; 1982; 4(2):219-25. PubMed ID: 6279493 [TBL] [Abstract][Full Text] [Related]
55. Plasma renin activities and the detection of angiotensin dependent hypertension. Scharpe SL; Van Acker KJ; Deprettere AJ; De Broe ME; Lauwers AR; Verkerk RM Clin Biochem; 1979 Dec; 12(6):234-5. PubMed ID: 394882 [No Abstract] [Full Text] [Related]
56. The influence of ACE-inhibition by captopril on renal formation and metabolism of angiotensins I and II in patients with renovascular hypertension. Hesse B; Rasmussen S; Giese J; Nielsen MD; Høilund-Carlsen PF Scand J Urol Nephrol Suppl; 1984; 79():45-8. PubMed ID: 6089318 [TBL] [Abstract][Full Text] [Related]
57. Serum angiotensin converting enzyme activity and the capacity to develop hypertention-associated arterial disease. Studies during the induction phase of one-kidney perinephritis hypertension in rabbits. Campbell WG; Donohue JA; Duket LH Am J Pathol; 1978 Nov; 93(2):383-404. PubMed ID: 213977 [TBL] [Abstract][Full Text] [Related]
58. Effects of converting enzyme inhibitor (SQ 20881) on changes in blood pressure and plasma aldosterone induced by angiotensin I or acute hemorrhage in rabbits. Saito I; Eguchi T; Nakamura R; Misumi J; Kondo K; Saruta T Jpn Heart J; 1980 Jan; 21(1):95-101. PubMed ID: 6154159 [TBL] [Abstract][Full Text] [Related]
59. Effects of the converting enzyme inhibitor (SQ 20881) on the pulmonary circulation in man. Niarchos AP; Roberts AJ; Laragh JH Am J Med; 1979 Nov; 67(5):785-91. PubMed ID: 315711 [TBL] [Abstract][Full Text] [Related]